IL153708A0 - Benzimidazole derivatives, preparation and therapeutic use thereof - Google Patents

Benzimidazole derivatives, preparation and therapeutic use thereof

Info

Publication number: IL153708A0
Authority: IL; Israel
Prior art keywords: preparation; therapeutic use; benzimidazole derivatives; benzimidazole; derivatives
Prior art date: 2000-08-08

Application number

IL15370801A

Other languages

English (en)

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-08

Filing date

2001-08-06

Publication date

2003-07-06

2000-08-08 Priority claimed from FR0010419A external-priority patent/FR2812878B1/fr

2000-11-15 Priority claimed from FR0014696A external-priority patent/FR2816619B1/fr

2001-08-06 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2003-07-06 Publication of IL153708A0 publication Critical patent/IL153708A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Virology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Endocrinology (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Transplantation (AREA)
Communicable Diseases (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)

IL15370801A 2000-08-08 2001-08-06 Benzimidazole derivatives, preparation and therapeutic use thereof IL153708A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0010419A FR2812878B1 (fr)	2000-08-08	2000-08-08	Derives de benzimidazole, leur preparation et leur application en therapeutique
FR0014696A FR2816619B1 (fr)	2000-11-15	2000-11-15	Derives de benzimidazole, leur preparation et leur application en therapeutique
PCT/FR2001/002556 WO2002012239A1 (fr)	2000-08-08	2001-08-06	Derives de benzimidazole, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
IL153708A0 true IL153708A0 (en)	2003-07-06

Family

ID=26212570

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15370801A IL153708A0 (en)	2000-08-08	2001-08-06	Benzimidazole derivatives, preparation and therapeutic use thereof

Country Status (28)

Country	Link
US (2)	US6794382B2 (de)
EP (1)	EP1309594B1 (de)
JP (1)	JP2004505975A (de)
KR (1)	KR20030020450A (de)
CN (1)	CN1446218A (de)
AR (1)	AR030121A1 (de)
AT (1)	ATE284886T1 (de)
AU (1)	AU2001282267A1 (de)
BG (1)	BG107460A (de)
BR (1)	BR0113046A (de)
CA (1)	CA2412368A1 (de)
CZ (1)	CZ294493B6 (de)
DE (1)	DE60107859T2 (de)
EA (1)	EA005950B1 (de)
EE (1)	EE200300048A (de)
ES (1)	ES2233671T3 (de)
HK (1)	HK1053118A1 (de)
HR (1)	HRP20030081A2 (de)
HU (1)	HUP0301514A2 (de)
IL (1)	IL153708A0 (de)
IS (1)	IS6661A (de)
MX (1)	MXPA03000753A (de)
NO (1)	NO20030596L (de)
PL (1)	PL365080A1 (de)
PT (1)	PT1309594E (de)
SK (1)	SK1582003A3 (de)
WO (1)	WO2002012239A1 (de)
YU (1)	YU7203A (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050119251A1 (en) *	2001-12-21	2005-06-02	Jian-Min Fu	Nicotinamide derivatives and their use as therapeutic agents
US20040014744A1 (en) *	2002-04-05	2004-01-22	Fortuna Haviv	Substituted pyridines having antiangiogenic activity
AU2003240742A1 (en) *	2002-06-07	2003-12-22	Altana Pharma Ag	4,5-dihydro-imidazo (4,5,1-ij) quinolin-6-ones derivatives and their use as poly (adp-ribosyl) transferase (parp) inhibitors
AU2003236686A1 (en) *	2002-06-07	2003-12-22	Altana Pharma Ag	4,5-dihydro-imidazo(4,5,1-j) quinolin-6-ones as parp inhibitors
WO2004108723A1 (en) *	2003-06-04	2004-12-16	Altana Pharma Ag	4,5-dihydro-imidazo[4,5,1-ii]quinolin-6-ones as parp inhibitors
GB0317466D0 (en) *	2003-07-25	2003-08-27	Univ Sheffield	Use
PL1684736T3 (pl)	2003-12-01	2012-01-31	Kudos Pharm Ltd	Inhibitory naprawy DNA w leczeniu raka
TW200626148A (en) *	2004-09-20	2006-08-01	Xenon Pharmaceuticals Inc	Heterocyclic derivatives and their use as therapeutic agents
AU2005286728A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP1799667B1 (de) *	2004-09-20	2013-03-20	Xenon Pharmaceuticals Inc.	Heterozyklische derivate und ihre verwendung als therapeutische wirkstoffe
US7919496B2 (en)	2004-09-20	2011-04-05	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
JP4958785B2 (ja) *	2004-09-20	2012-06-20	ゼノン・ファーマシューティカルズ・インコーポレイテッド	複素環誘導体およびステアロイル−ＣｏＡデサチュラーゼインヒビターとしてのそれらの使用
BRPI0515499A (pt) *	2004-09-20	2008-07-29	Xenon Pharmaceuticals Inc	derivados de piridina para a inibição de estearoil-coa-desaturase humana
WO2006034341A2 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
WO2006034441A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
US7767677B2 (en)	2004-09-20	2010-08-03	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
WO2006074991A1 (en) *	2005-01-11	2006-07-20	Neurosearch A/S	Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
EP2029138A1 (de) *	2005-06-03	2009-03-04	Xenon Pharmaceuticals Inc.	Aminothiazolderivate als humane stearoyl-coa desaturasehemmer
WO2007018998A2 (en) *	2005-08-05	2007-02-15	Astrazeneca Ab	Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
CA2654666A1 (en) *	2006-07-03	2008-01-10	Neurosearch A/S	Pharmaceutical compositions
GB0716532D0 (en)	2007-08-24	2007-10-03	Angeletti P Ist Richerche Bio	Therapeutic compounds
GB201220157D0 (en) *	2012-11-08	2012-12-26	Selvita Sa	Substitute tricyclic benzimidazoles as kinase inhibitors
CN103923088B (zh) *	2013-01-11	2016-09-07	上海汇伦生命科技有限公司	2,5-二氮杂双环[2.2.1]庚烷类化合物和制备方法、其药用组合物及其在医药上的应用
SG10201707487VA (en) *	2013-03-15	2017-10-30	Incyte Corp	Tricyclic heterocycles as bet protein inhibitors
CN104230896A (zh) *	2013-06-17	2014-12-24	上海汇伦生命科技有限公司	苯并咪唑-2-哌嗪杂环类化合物、其药物组合物及其制备方法和用途
US9309246B2 (en)	2013-12-19	2016-04-12	Incyte Corporation	Tricyclic heterocycles as BET protein inhibitors
PT3134403T (pt)	2014-04-23	2020-05-18	Incyte Corp	1h-pirrolo[2,3-c]piridin-7(6h)-onas e pirazolo[3,4-c]piridin-7(6h)-onas como inibidores das proteínas bet
BR112017025367A2 (pt) *	2015-05-29	2018-08-07	Shionogi & Co., Ltd.	derivados tricíclicos contendo nitrogênio tendo atividade inibidora de replicação de hiv
PE20240236A1 (es)	2016-06-20	2024-02-16	Incyte Corp	Formas solidas cristalinas de un inhibidor de bet
CN110661676B (zh) *	2018-06-29	2022-06-28	大唐移动通信设备有限公司	一种带宽部分的测量方法、配置方法、终端及网络设备
CN111349094B (zh) *	2020-04-23	2021-02-02	杭州师范大学	一种6H-咪唑[4,5,1-ij]并喹诺酮及其合成方法和应用
US11833155B2 (en)	2020-06-03	2023-12-05	Incyte Corporation	Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2710915B1 (fr)	1993-10-04	1995-11-24	Synthelabo	Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
FR2731708B1 (fr) *	1995-03-13	1997-04-30	Synthelabo	Derives de piperidine, leur procede de preparation et leur application en therapeutique
NZ511825A (en) *	1998-11-27	2003-08-29	Basf Ag	Substituted benzimidazoles and their use as parp inhibitors

2001
- 2001-08-06 CA CA002412368A patent/CA2412368A1/fr not_active Abandoned
- 2001-08-06 AR ARP010103751A patent/AR030121A1/es not_active Application Discontinuation
- 2001-08-06 PT PT01960871T patent/PT1309594E/pt unknown
- 2001-08-06 BR BR0113046-3A patent/BR0113046A/pt not_active IP Right Cessation
- 2001-08-06 HU HU0301514A patent/HUP0301514A2/hu unknown
- 2001-08-06 EP EP01960871A patent/EP1309594B1/de not_active Expired - Lifetime
- 2001-08-06 MX MXPA03000753A patent/MXPA03000753A/es unknown
- 2001-08-06 JP JP2002518214A patent/JP2004505975A/ja active Pending
- 2001-08-06 EA EA200201259A patent/EA005950B1/ru not_active IP Right Cessation
- 2001-08-06 WO PCT/FR2001/002556 patent/WO2002012239A1/fr active IP Right Grant
- 2001-08-06 AT AT01960871T patent/ATE284886T1/de not_active IP Right Cessation
- 2001-08-06 PL PL01365080A patent/PL365080A1/xx not_active Application Discontinuation
- 2001-08-06 AU AU2001282267A patent/AU2001282267A1/en not_active Abandoned
- 2001-08-06 ES ES01960871T patent/ES2233671T3/es not_active Expired - Lifetime
- 2001-08-06 CN CN01813895A patent/CN1446218A/zh active Pending
- 2001-08-06 IL IL15370801A patent/IL153708A0/xx unknown
- 2001-08-06 US US10/343,467 patent/US6794382B2/en not_active Expired - Fee Related
- 2001-08-06 YU YU7203A patent/YU7203A/sh unknown
- 2001-08-06 CZ CZ2003354A patent/CZ294493B6/cs not_active IP Right Cessation
- 2001-08-06 DE DE60107859T patent/DE60107859T2/de not_active Expired - Lifetime
- 2001-08-06 KR KR10-2003-7001760A patent/KR20030020450A/ko not_active Application Discontinuation
- 2001-08-06 EE EEP200300048A patent/EE200300048A/xx unknown
- 2001-08-06 SK SK158-2003A patent/SK1582003A3/sk unknown
2002
- 2002-12-19 IS IS6661A patent/IS6661A/is unknown
2003
- 2003-01-14 BG BG107460A patent/BG107460A/bg unknown
- 2003-02-06 HR HR20030081A patent/HRP20030081A2/hr not_active Application Discontinuation
- 2003-02-06 NO NO20030596A patent/NO20030596L/no not_active Application Discontinuation
- 2003-07-28 HK HK03105435A patent/HK1053118A1/xx not_active IP Right Cessation
2004
- 2004-09-13 US US10/939,910 patent/US20050032779A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2233671T3 (es)	2005-06-16
EP1309594A1 (de)	2003-05-14
IS6661A (is)	2002-12-19
SK1582003A3 (en)	2003-08-05
JP2004505975A (ja)	2004-02-26
CN1446218A (zh)	2003-10-01
PT1309594E (pt)	2005-04-29
WO2002012239A1 (fr)	2002-02-14
MXPA03000753A (es)	2003-10-15
CZ294493B6 (cs)	2005-01-12
EE200300048A (et)	2004-12-15
EA200201259A1 (ru)	2003-06-26
PL365080A1 (en)	2004-12-27
EA005950B1 (ru)	2005-08-25
DE60107859T2 (de)	2005-12-22
US20050032779A1 (en)	2005-02-10
CZ2003354A3 (cs)	2003-05-14
HK1053118A1 (en)	2003-10-10
HRP20030081A2 (en)	2005-02-28
YU7203A (sh)	2006-01-16
EP1309594B1 (de)	2004-12-15
DE60107859D1 (de)	2005-01-20
NO20030596D0 (no)	2003-02-06
US20030203893A1 (en)	2003-10-30
BR0113046A (pt)	2003-07-01
HUP0301514A2 (hu)	2003-09-29
BG107460A (bg)	2003-09-30
AU2001282267A1 (en)	2002-02-18
NO20030596L (no)	2003-04-01
US6794382B2 (en)	2004-09-21
KR20030020450A (ko)	2003-03-08
CA2412368A1 (fr)	2002-02-14
AR030121A1 (es)	2003-08-13
ATE284886T1 (de)	2005-01-15

Publication	Publication Date	Title
IL153708A0 (en)	2003-07-06	Benzimidazole derivatives, preparation and therapeutic use thereof
HUP0401461A3 (en)	2009-06-29	Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HK1048999A1 (zh)	2003-04-25	氮雜䓬吲衍生物，它們的製備和應用
IL145150A0 (en)	2002-06-30	Pyridopyranoazepine derivatives, preparation and therapeutic use
HUP0105039A3 (en)	2002-05-28	Fungicidal propargylether derivatives, preparation and use thereof
HK1076110A1 (en)	2006-01-06	Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
TWI318974B (en)	2010-01-01	Acylaminothiazole derivatives, their preparation and their therapeutic use
AU2001264044A1 (en)	2001-12-11	1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
IL135451A0 (en)	2001-05-20	3-amino-3-arylpropan-1-ol derivatives, their preparation and use
PT1525193E (pt)	2008-02-25	Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide
HK1074444A1 (en)	2005-11-11	Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
AU2001284084A1 (en)	2002-01-30	Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
PL365342A1 (en)	2004-12-27	Mikanolide derivatives, their preparation and therapeutic uses
HUP0203468A3 (en)	2003-03-28	Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
IL135452A0 (en)	2001-05-20	3-amino-3-arylpropan-1-ol derivatives, their preparation and use
HK1065792A1 (en)	2005-03-04	3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
SI1309594T1 (en)	2005-04-30	Benzimidazole derivatives, preparation and therapeutic use thereof
IL149653A0 (en)	2002-11-10	2-arylquinoline derivatives, preparation and therapeutic use thereof
IL150237A0 (en)	2002-12-01	Benzophenone glycopyranosides, preparation and therapeutic use
SI1161434T1 (en)	2003-06-30	Pyridopyranoazepine derivatives, preparation and therapeutic use
SI1212313T1 (en)	2004-06-30	7-carboxy-flavone derivatives, preparation method and therapeutic use
GB0025582D0 (en)	2000-12-06	Benzimidazole compounds, their preparation and their use in therapy
AU2001237517A1 (en)	2001-09-12	Haloimidazole derivatives, their preparation and therapeutic use
HK1063793A1 (en)	2005-01-14	Mikanolide derivatives, their preparation and therapeutic uses
SI1525198T1 (sl)	2006-04-30	Derivati aciloksi pirolidina in njihova uporaba kot ligandi receptorjev V1b ali V1b in V1a od AVP